Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-15

FDA Approved: OXYTROL FOR WOMEN — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OXYTROL FOR WOMEN (oxybutynin) submitted by Allergan, Inc. This action updates the product's labeling for use in wom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYTROL FOR WOMEN (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL FOR WOMEN (OXYBUTYNIN)